Systemic sarcoidosis after treatment with pegylated interferon-alpha;Sarcoïdose systémique au décours d'un traitement par interféron-alpha pégylé

Revue de Medecine Interne

Volumn 31, Issue 4, 2010, Pages

  Le Bras, M ^a   Hervier, B ^a   Wastiaux, H ^a   Masseau, A ^a   Durant, C ^a   Jossic, F ^a   Hamidou, M ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Alpha interferon; Chronic hepatitis C; Sarco dosis; Systemic granulomatosis

Indexed keywords

PEGINTERFERON ALPHA; RIBAVIRIN;

ADULT; ARTICLE; ASTHENIA; CASE REPORT; CD4 LYMPHOCYTE COUNT; ERYTHEMA; EYE; FEMALE; HEPATITIS C; HUMAN; LUNG SARCOIDOSIS; MYALGIA; SARCOIDOSIS; SKIN; SYSTEMIC DISEASE;

FEMALE; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; SARCOIDOSIS;

EID: 77950628340     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.03.366     Document Type: Article

References (13)

1. Vital D.D., Durieu I., Rousset H. Toxic or drug-induced granulomatous reactions. Rev Med Interne 2008, 29:33-38.
2. Abdi E.A., Nguyen G.K., Ludwig R.N., Dickout W.J. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 1987, 59:896-900.
3. Ramos-Casals M., Mana J., Nardi N., Brito-Zeron P., Xaubet A., Sanchez-Tapias J.M., et al. Sarcoidosis in patients with chronic hepatitis C virus infection: Analysis of 68 cases. Medicine 2005, 84:69-80.
4. Pelletier F., Manzoni P., Jacoulet P., Humbert P., Aubin F. Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma. Cutis 2007, 80:441-445.
5. Moller D.R., Forman J.D., Liu M.C., Noble P.W., Greenlee B.M., Vyas P., et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996, 156:4952-4960.
6. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006, 203:359-370.
7. Leclerc S., Myers R.P., Moussalli J., Herson S., Poynard T., Benveniste O. Sarcoidosis and interferon therapy: Report of five cases and review of the literature. Eur J Intensive Care Med 2003, 14:237-243.
8. Veerabagu M.P., Finkelstein S.D., Rabinovitz M. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha. Dig Dis Sci 1997, 42:1445-1448.
9. Butnor K.J. Pulmonary sarcoidosis induced by interferon-alpha therapy. Am J Surg Pathol 2005, 29:976-979.
10. Midturi J., Sierra-Hoffman M., Hurley D., Winn R., Beissner R., Carpenter J. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: Case report and review of the literature. Clin Infect Dis 2004, 39:1724-1729.
11. Alazemi S., Campos M.A. Interferon-induced sarcoidosis. Int J Clin Pract 2006, 60:201-211.
12. Hurst E.A., Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: A case report and review of the literature. Arch Dermatol 2005, 141:865-868.
13. Charlier C., Nunes H., Trinchet J.C., Roullet E., Mouthon L., Beaugrand M., et al. Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease. Eur Respir J 2005, 25:570-573.